Sage Therapeutics Income Statement

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	39.1	38.39	23.57	-	-	-	Upgrade
Revenue Growth (YoY)	32.84%	62.86%	-	-	-	-	Upgrade
Cost of Revenue	15.21	14.51	7.37	-	-	-	Upgrade
Gross Profit	23.88	23.88	16.21	-	-	-	Upgrade
Selling, General & Admin	17.64	17.11	12.95	1.22	1.65	2.37	Upgrade
Operating Expenses	17.65	17.13	12.89	1.22	1.65	2.37	Upgrade
Operating Income	6.23	6.75	3.31	-1.22	-1.65	-2.37	Upgrade
Interest Expense	-0.12	-0.07	-0.01	-	-	-	Upgrade
Interest & Investment Income	0.11	0.13	0.09	0.02	-	-	Upgrade
Earnings From Equity Investments	0.42	0.32	0.02	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0.68	0.49	0.17	-	0.02	0	Upgrade
Pretax Income	7.32	7.62	3.58	-1.2	-1.62	-2.36	Upgrade
Income Tax Expense	2.23	2.36	1.52	-	-	-	Upgrade
Earnings From Continuing Operations	5.09	5.27	2.06	-1.2	-1.62	-2.36	Upgrade
Net Income to Company	5.09	5.27	2.06	-1.2	-1.62	-2.36	Upgrade
Minority Interest in Earnings	-0.03	-0.07	-0.6	-	-	-	Upgrade
Net Income	5.06	5.2	1.46	-1.2	-1.62	-2.36	Upgrade
Net Income to Common	5.06	5.2	1.46	-1.2	-1.62	-2.36	Upgrade
Net Income Growth	99.82%	255.06%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	354	352	262	135	135	135	Upgrade
Shares Outstanding (Diluted)	354	352	262	135	135	135	Upgrade
Shares Change (YoY)	30.58%	34.41%	94.56%	-	-	-	Upgrade
EPS (Basic)	0.01	0.01	0.01	-0.01	-0.01	-0.02	Upgrade
EPS (Diluted)	0.01	0.01	0.01	-0.01	-0.01	-0.02	Upgrade
EPS Growth	53.03%	164.17%	-	-	-	-	Upgrade
Free Cash Flow	-3.72	-4.49	0.75	-1.17	-1.64	-1.3	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	0.00	-0.01	-0.01	-0.01	Upgrade
Gross Margin	61.08%	62.20%	68.74%	-	-	-	Upgrade
Operating Margin	15.93%	17.59%	14.04%	-	-	-	Upgrade
Profit Margin	12.93%	13.54%	6.21%	-	-	-	Upgrade
Free Cash Flow Margin	-9.51%	-11.70%	3.17%	-	-	-	Upgrade
EBITDA	6.38	6.96	3.42	-	-	-	Upgrade
EBITDA Margin	16.32%	18.12%	14.52%	-	-	-	Upgrade
D&A For EBITDA	0.15	0.21	0.11	-	-	-	Upgrade
EBIT	6.23	6.75	3.31	-1.22	-1.65	-2.37	Upgrade
EBIT Margin	15.93%	17.59%	14.04%	-	-	-	Upgrade
Effective Tax Rate	30.53%	30.93%	42.44%	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.